Ursula Kees

Ursula Kees is an Adjunct Professor at the University of Western Australia (UWA), affiliated with the UWA Medical School and the Department of Paediatrics. Her research focuses on pediatric oncology, particularly acute lymphoblastic leukemia (ALL), with a strong emphasis on drug resistance mechanisms and novel therapeutic strategies. She has led or co-led 27 research grants, including projects on cancer genomics, drug testing in childhood tumors, and understanding leukemia biology.

• Education: Not explicitly stated in text.

Her research interests include leukemia pathobiology, targeted therapies for high-risk pediatric cancers, and translational drug development. Key areas of investigation involve osteoclast biology in leukemia treatment, azacitidine/venetoclax combinations for KMT2A-rearranged ALL, and auranofin's role in exploiting reactive oxygen species imbalances.

Recent work highlights include studies on NUT carcinoma epidemiology and preclinical evaluations of carfilzomib for infant leukemia. She has collaborated on multiple international projects and holds grants from organizations like the NHMRC and Australian Cancer Research Foundation. No specific awards are mentioned in the text.